Semi-Annual Statement Of Income And Retained Earnings

Oncolys BioPharma Inc. - Filing #7595769

Concept 2022-01-01 to
2022-06-30
2021-01-01 to
2021-06-30
Semi-annual statement of income and retained earnings
Statement of income and retained earnings
Operating profit (loss)
-658,898,000 JPY
-633,599,000 JPY
Non-operating income
Non-operating income
84,641,000 JPY
25,437,000 JPY
Non-operating expenses
Non-operating expenses
16,257,000 JPY
40,853,000 JPY
Ordinary profit (loss)
-590,514,000 JPY
-649,015,000 JPY
Extraordinary income
Extraordinary income
21,406,000 JPY
JPY
Profit (loss) before income taxes
-569,108,000 JPY
-649,015,000 JPY
Income taxes - current
1,461,000 JPY
1,844,000 JPY
Profit (loss)
-570,569,000 JPY
-650,860,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.